Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
26,611,315
Value
$2.41B
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202626,611,315$2.41B0.1%−3,490,281−11.6%ReducedHolders
Q1 202630,101,596$3.09B0.2%−6,625,937−18.0%ReducedHolders
Q4 202536,727,533$4.60B0.3%−1,907,263−4.9%ReducedHolders
Q3 202538,634,796$5.17B0.3%+3,428,144+9.7%AddedHolders
Q2 202535,206,652$4.79B0.3%−930,158−2.6%ReducedHolders
Q1 202536,136,810$4.79B0.3%+20,040+0.1%AddedHolders
Q4 202436,116,770$4.09B0.3%+1,603,355+4.6%AddedHolders
Q3 202434,513,415$3.93B0.3%−1,103,508−3.1%ReducedHolders
Q2 202435,616,923$3.70B0.3%−395,059−1.1%ReducedHolders
Q1 202436,011,982$4.09B0.3%+75,155+0.2%AddedHolders
Q4 202335,936,827$3.96B0.3%+296,425+0.8%AddedHolders
Q3 202335,640,402$3.45B0.4%−742,792−2.0%ReducedHolders
Q2 202336,383,194$3.97B0.4%−288,539−0.8%ReducedHolders
Q1 202336,671,733$3.71B0.4%−2,294,766−5.9%ReducedHolders
Q4 202238,966,499$4.28B0.5%+4,886,954+14.3%AddedHolders
Q3 202234,079,545$3.30B0.4%−2,364,827−6.5%ReducedHolders
Q2 202236,444,372$3.96B0.5%+6,560,294+22.0%AddedHolders
Q1 202229,884,078$3.54B0.5%+561,582+1.9%AddedHolders
Q4 202129,322,496$4.13B0.5%+902,174+3.2%AddedHolders
Q3 202128,420,322$3.36B0.5%−141,819−0.5%ReducedHolders
Q2 202128,562,141$3.31B0.4%+1,233,152+4.5%AddedHolders
Q1 202127,328,989$3.28B0.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.